References
Gavan, T. L., Barry, A. L.: Microdilution test procedures. In:Lennette, E. H., Balows, A., Housler, W. J., Truant, J. P. (ed.): Manual of clinical microbiology. American Society for Microbiology, Washington DC, 1980, p. 459.
Stobbetingh, E. H., Houben, A. W., van Boven, C. P. A.: SCH 34343, in vitro antibacterial activity and betalactamase stability. Journal of Antimicrobial Chemotherapy 1985, 15, Supplement C: 73–83.
Bell, S. H., Pham, J. R., Lanzarone, J. Y. M.: Mutation ofPseudomonas aeruginosa to piperacillin resistance mediated by beta-lactamase production. Journal of Antimicrobial Chemotherapy 1985, 15: 665–670.
Peeters, M., Piot, P.: In vitro activity of RO 15-8074, a new oral cephalosporin. Journal of Antimicrobial Chemotherapy 1985, 16: 469–473.
Thomas, M. G., Lang, S. D. R.: Antimicrobial spectrum of RO 15-8074/001, a new oral cephalosporin. Antimicrobial Agents and Chemotherapy 1986, 29: 945–947.
Wise, R., Andrews, J. H., Piddock, L. J. V.: In vitro activity of RO 15-8074 and RO 19-5247, two orally administered cephalosporin metabolites. Antimicrobial Agents and Chemotherapy 1986, 29: 1067–1072.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stobberingh, E., Houben, A.W. & van Boven, C.P.A. In vitro activity of the two new oral cephalosporins RO 15-8074 and RO 19-5247. Eur. J, Clin. Microbiol. 6, 489–490 (1987). https://doi.org/10.1007/BF02013119
Issue Date:
DOI: https://doi.org/10.1007/BF02013119